These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23239811)
1. MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma. Castro IC; Breiling A; Luetkenhaus K; Ceteci F; Hausmann S; Kress S; Lyko F; Rudel T; Rapp UR Mol Cancer Res; 2013 Feb; 11(2):161-72. PubMed ID: 23239811 [TBL] [Abstract][Full Text] [Related]
2. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma. Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441 [No Abstract] [Full Text] [Related]
3. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma. Yamamura N; Kishimoto T Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas. Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129 [TBL] [Abstract][Full Text] [Related]
5. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis. Xi S; Xu H; Shan J; Tao Y; Hong JA; Inchauste S; Zhang M; Kunst TF; Mercedes L; Schrump DS J Clin Invest; 2013 Mar; 123(3):1241-61. PubMed ID: 23426183 [TBL] [Abstract][Full Text] [Related]
6. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas. Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040 [TBL] [Abstract][Full Text] [Related]
7. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the GATA genes in lung cancer. Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625 [TBL] [Abstract][Full Text] [Related]
9. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Allen TD; Rodriguez EM; Jones KD; Bishop JM Cancer Res; 2011 Sep; 71(18):6010-8. PubMed ID: 21803744 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome. Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450 [TBL] [Abstract][Full Text] [Related]
11. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205 [TBL] [Abstract][Full Text] [Related]
12. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer]. Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway. Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422 [TBL] [Abstract][Full Text] [Related]
14. ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms. Lee HJ; Seol HS; Kim JY; Chun SM; Suh YA; Park YS; Kim SW; Choi CM; Park SI; Kim DK; Kim YH; Jang SJ Ann Surg Oncol; 2013 Jan; 20(1):200-8. PubMed ID: 22915320 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers. Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Ishizuka T; Saito R; Nakajima T; Mori M Int J Oncol; 2007 Jul; 31(1):169-73. PubMed ID: 17549418 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of Myc. Fukazawa T; Maeda Y; Matsuoka J; Yamatsuji T; Shigemitsu K; Morita I; Faiola F; Durbin ML; Soucek L; Naomoto Y Anticancer Res; 2010 Oct; 30(10):4193-200. PubMed ID: 21036740 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells. Lu Y; Liu Y; Liao S; Tu W; Shen Y; Yan Y; Tao D; Lu Y; Ma Y; Yang Y; Zhang S Oncotarget; 2016 Jul; 7(28):43162-43176. PubMed ID: 27281610 [TBL] [Abstract][Full Text] [Related]
18. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells. Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589 [TBL] [Abstract][Full Text] [Related]
19. [Expression of surviving gene and its relationship with expression of P53, c-myc, k-ras proteins in non-small-cell lung cancer]. Wang X; Chen S; Zhang Z Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):371-4. PubMed ID: 11802993 [TBL] [Abstract][Full Text] [Related]
20. WT1 enhances proliferation and impedes apoptosis in KRAS mutant NSCLC via targeting cMyc. Wu C; Wang S; Xu C; Tyler A; Li X; Andersson C; Oji Y; Sugiyama H; Chen Y; Li A Cell Physiol Biochem; 2015; 35(2):647-62. PubMed ID: 25613309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]